About Kano Therapeutics
Kano Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $5,050,000 raised in one offering on Form D since May 2024. Its chief executive is Floris Engelhardt.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 6, 2024 | May 20, 2024 | $5,050,000fully sold | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kano Therapeutics's Form D filed May 20, 2024.